enow.com Web Search

  1. Ad

    related to: diffuse liver disease mri with contrast

Search results

  1. Results from the WOW.Com Content Network
  2. Tomoelastography - Wikipedia

    en.wikipedia.org/wiki/Tomoelastography

    Currently, most applications of tomoelastography are based on MRI, which is why tomoelastography is often referred to as an advanced MRE technique. Multifrequency-MRE based tomoelastography has been used for the diagnosis of diffuse liver disease, [9] [10] [11] renal diseases such as renal allograft dysfunction, [12] lupus nephritis, [13] and immunoglobulin A nephropathy (IgAN). [14]

  3. Diffusion-weighted magnetic resonance imaging - Wikipedia

    en.wikipedia.org/wiki/Diffusion-weighted...

    When water is in an environment where it can freely tumble, relaxation tends to take longer. In certain clinical situations, this can generate contrast between an area of pathology and the surrounding healthy tissue. To sensitize MRI images to diffusion, the magnetic field strength (B1) is varied linearly by a pulsed field gradient.

  4. Transient hepatic attenuation differences - Wikipedia

    en.wikipedia.org/wiki/Transient_hepatic...

    Transient hepatic attenuation differences (THAD) are areas of enhancement during the arterial phase of contrast CT of the liver. THAD is thought to be a physiological phenomenon resulting from regional variation in the blood supply by the portal vein and/or the hepatic artery .

  5. Magnetic resonance imaging - Wikipedia

    en.wikipedia.org/wiki/Magnetic_resonance_imaging

    Focal or diffuse disorders of the liver may be evaluated using diffusion-weighted, opposed-phase imaging and dynamic contrast enhancement sequences. Extracellular contrast agents are used widely in liver MRI, and newer hepatobiliary contrast agents also provide the opportunity to perform functional biliary imaging.

  6. LI-RADS - Wikipedia

    en.wikipedia.org/wiki/LI-RADS

    The Liver Imaging Reporting and Data System (aka LI-RADS) is a quality assurance tool created and trademarked by the American College of Radiology in 2011 to standardize the reporting and data collection of CT and MR imaging patients at risk for hepatocellular carcinoma (HCC), or primary cancer of the liver cells. [1]

  7. MRI contrast agent - Wikipedia

    en.wikipedia.org/wiki/MRI_contrast_agent

    A contrast agent usually shortens, but in some instances increases, the value of T1 of nearby water protons thereby altering the contrast in the image. Most clinically used MRI contrast agents work by shortening the T1 relaxation time of protons inside tissues via interactions with the nearby contrast agent.

  8. Cirrhosis - Wikipedia

    en.wikipedia.org/wiki/Cirrhosis

    Cirrhosis, also known as liver cirrhosis or hepatic cirrhosis, chronic liver failure or chronic hepatic failure and end-stage liver disease, is an acute condition of the liver in which the normal functioning tissue, or parenchyma, is replaced with scar tissue and regenerative nodules as a result of chronic liver disease.

  9. Hepatomegaly - Wikipedia

    en.wikipedia.org/wiki/Hepatomegaly

    A complete blood test can help distinguish intrinsic liver disease from extrahepatic bile-duct obstruction. [19] An ultrasound of the liver can reliably detect a dilated biliary-duct system, [20] it can also detect the characteristics of a cirrhotic liver. [21] Computerized tomography (CT) can give accurate anatomical information for a complete ...

  1. Ad

    related to: diffuse liver disease mri with contrast